NCT05318144

Melatonin Levels on COVID-19 Positive Pregnant Women

Prognostic Value of Serum Melatonin as a Biomarker for the Determination of Severe COVID-19 Infection in Pregnant Women

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 228 (actual)
• Sponsor: Nazan Yurtcu MD · Academic / Other
• Sex: Female
• Age: 18 Years – 40 Years
• Healthy volunteers: Accepted

Summary

This study aimed to investigate the prognostic value of serum melatonin as a biomarker for the determination of severe COVID-19 infection in pregnant women. Four study groups were formed, including pregnant women with a positive COVID-19 PCR test, severe symptoms, and inpatient treatment. Pregnant women who had complaints similar to COVID-19 infection or had no complaints, but had a PCR test due to the surveillance program and negative test results were included in the control group. Methods and Main Outcome measure: Laboratory values of the cases at the time of diagnosis parameters were collected. Melatonin levels decrease in pregnant women with COVID-19 symptoms, the severity of symptoms increases. In addition, patients with low melatonin levels have an increase in infection parameters and an increase in the hospital stay.

Detailed description

A total of 228 pregnant women included in this prospective controlled study between June 20021 and June 2022 at Gynecology and Obstetrics Department of Health Sciences University Samsun Training and Research Hospital.

Conditions

• COVID-19 Acute Respiratory Distress Syndrome
• Pregnancy Related
• Pregnancy Complications

Interventions

Type	Name	Description
OTHER	—

Timeline

• Start date: 2021-06-01
• Primary completion: 2021-12-01
• Completion: 2022-02-01
• First posted: 2022-04-08
• Last updated: 2022-04-08

Locations

1 site across 1 country: Turkey (Türkiye)